Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2012
04/05/2012WO2011143317A3 Methods for the regulation of cellular metabolism through the modulation of sirt3 activity
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083587 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082715 Stabilized products, processes and devices for preparing the same
04/05/2012US20120082678 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
04/05/2012US20120082658 Methods for the Treatment of Allergic Diseases
04/05/2012US20120082650 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
04/05/2012DE102011000036A1 Rekombinante plasmidhaltige Mehrkopie-CpG-Motive und deren Transformanten zur Anwendung als DNA-Adjuvans in Vogel-Impfstoffen Recombinant plasmid-containing multi-copy CpG motifs and their transformants for use as DNA adjuvant in vaccines Bird
04/05/2012CA2813013A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
04/05/2012CA2809360A1 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
04/04/2012EP2436756A2 Selective infarcted-tissue-targeting bacteria and use thereof
04/04/2012EP2436399A1 Polymeric nano-particles for siRNA delivery using charge interaction and covalent bonding
04/04/2012EP2436387A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
04/04/2012EP2435566A2 Tumour-specific bacterial promoter elements
04/04/2012EP2435559A1 Simian adenovirus 41 and uses thereof
04/04/2012EP2435558A2 Generation of genetically corrected disease-free induced pluripotent stem cells
04/04/2012EP2435076A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
04/04/2012EP1704243B1 Oligonucleotide compound and method for treating nidovirus infections
04/04/2012EP1466001B1 Viruses with enhanced lytic potency medikament
04/04/2012CN102399870A 一种确定食道癌病人生存预后的试剂 A method of determining the prognosis of esophageal cancer patients survive reagents
04/04/2012CN102399820A Small interfering RNA directed at HPV16 E7 gene and its application
04/04/2012CN102399809A 一种非病毒型转染试剂、其与质粒dna复合物制备方法及应用 A non-viral transfection reagent preparation method and application plasmid dna complex
04/04/2012CN102399807A 猪传染性胃肠炎s/n蛋白融合基因及重组乳酸乳球菌和应用 Transmissible Gastroenteritis s / n protein fusion gene and recombinant Lactococcus lactis and applications
04/04/2012CN102399806A 猪流行性腹泻S<sub>1</sub>蛋白融合基因及重组巨大芽孢杆菌和应用 Porcine epidemic diarrhea S <sub> 1 </ sub> fusion gene and recombinant protein of Bacillus megaterium and applications
04/04/2012CN102399805A 猪传染性胃肠炎病毒抗原融合基因及重组巨大芽孢杆菌菌株和应用 Porcine transmissible gastroenteritis virus antigen fusion gene and recombinant strains of Bacillus megaterium and applications
04/04/2012CN102399780A 抑制手足口病病毒基因的干扰rna, 包含其的载体及其应用 Rna interference suppression foot and mouth disease virus gene, including its carrier and its application
04/04/2012CN102399778A 一组下调Mortalin/HSPA9/Grp75表达的siRNA分子及其应用 A set down Mortalin / HSPA9 / Grp75 expression of siRNA molecules and its application
04/04/2012CN102399777A Recombinant plasmid and recombinant oncolytic virus prepared by using the same
04/04/2012CN102399284A 狐狸生长激素释放激素cDNA及其应用 Fox ghrelin cDNA and Its Applications
04/04/2012CN102399283A 水貂生长激素释放激素cDNA及其应用 Mink growth hormone releasing hormone cDNA and Its Applications
04/04/2012CN102397560A Preparation method for avian pasteurella genome vaccine
04/04/2012CN102397557A Modification method for gold nanorods and gold nanorods-functional molecule composite
04/03/2012US8148509 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
04/03/2012US8148346 Compositions and methods for the systemic treatment of arthritis
04/03/2012US8148343 Tumor suppressor factor
04/03/2012US8148322 Method and carrier complexes for delivering molecules to cells
04/03/2012US8148145 Virus coat protein variants with self-subtracting properties
04/03/2012US8148136 Diagnostics and vaccines for mycobacterial infections of animals and humans
04/03/2012US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
04/03/2012US8148114 Materials and methods for treatment of inflammatory and cell proliferation disorders
04/03/2012US8148109 Interferon-like proteins and uses thereof
04/03/2012US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof
04/03/2012US8148060 Recombinant viral vector for gene transfer into lymphoid cells
04/03/2012US8147860 Porous calcium phosphate bone material
04/03/2012US8147845 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
04/03/2012US8147823 Method of treating or retarding the development of blindness
04/03/2012US8147822 Oncolytic virus
04/03/2012CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2374675C Modified factor viii
03/2012
03/29/2012WO2012040266A2 Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines
03/29/2012WO2012040184A2 Novel low molecular weight cationic lipids for oligonucleotide delivery
03/29/2012WO2012040105A2 Renilla/gaussia transfected cells as a light source for in-situ photodynamic therapy of cancer
03/29/2012WO2012038956A1 Method of treating neurodegenerative diseases
03/29/2012WO2012037779A1 FUSION PROTEIN SAmB, CODING GENE AND APPLICATION THEREOF
03/29/2012WO2011139907A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
03/29/2012WO2011116351A3 Methods and compositions for the treatment of cancer
03/29/2012US20120077870 Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077861 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
03/29/2012US20120077741 Treatment of Central Nervous System Disorders
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120077265 MicroRNA and Methods for Inhibiting Same
03/29/2012US20120076853 Composition for use in gene therapy
03/29/2012US20120076852 Drug carrier and drug carrier kit for inhibiting fibrosis
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076735 Nanoparticles for Extravascular Administration
03/29/2012DE102010046866A1 Diagnosing diseases of central nervous system e.g. primary lymphoma, comprises determining content of microRNA highly diagnostic for presence or absence of disease in a sample of cerebrospinal fluid, and comparing with a reference value
03/29/2012CA2809858A1 Novel low molecular weight cationic lipids for oligonucleotide delivery
03/28/2012EP2434017A2 Identification of a micro-RNA that activates expression of beta-myosin heavy chain
03/28/2012EP2433641A1 Obligate heterodimer meganucleases and uses thereof
03/28/2012EP2433492A1 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
03/28/2012EP2432893A1 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs
03/28/2012EP2432882A2 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
03/28/2012EP2432881A2 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/28/2012EP2432467A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
03/28/2012EP1766077B1 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
03/28/2012EP1651667B1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012CN102395381A Compositions and methods for preventing cardiac arrhythmia
03/28/2012CN102392049A Preparation method for hepatitis E virus antigen and product thereof
03/28/2012CN102392048A Recombinant vaccinia virus rMVA-mep for expressing Japanese encephalitis virus E protein multi-epitope antigen and application thereof
03/28/2012CN102392031A Schistosoma japonicum thioredoxin glutathione reductase gene and DNA (deoxyribonucleic acid) vaccine thereof
03/28/2012CN102391372A Target of liver cancer drug therapy and application of the target
03/28/2012CN102389575A Genetic engineering oral DNA vaccine and preparation method and application
03/28/2012CN102389574A Application of ITPKA (inositol-trisphosphate 3-kinase A) gene and expression protein thereof in preparing and screening anti-cancer medicament
03/28/2012CN102389413A Composition used for treating diabetes mellitus, and application thereof
03/28/2012CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof
03/28/2012CN101291678B Carrier composition for nucleic acid transport
03/27/2012US8143390 Compositions and methods for inhibiting expression of anti-apoptotic genes
03/27/2012US8143241 DNA damage repair inhibitors for treatment of cancer
03/27/2012US8143229 Method for production of a transformed cell
03/27/2012US8143213 Effect of TULA on HIV
03/27/2012US8142990 Dermal micro-organs, methods and apparatuses for producing and using the same
03/27/2012US8142794 Hepatitis C virus vaccine
03/27/2012US8142773 Isolating progenitor cell tissue via antibody specific binding, transfering into recipient host, monitor cell propagation; tissue engineering; regenerative medicine
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 870